- ERBA Diagnostics (NYSEMKT:ERB -11.1%) FY2014 results: Revenues: $26.4M (-6.7%); COGS: $13.8M (-4.2%); Operating Expenses: $11.7M (-8.6%); Operating Income: $0.9M (-10.0%); Net Income: $0.4M (-42.9%); EPS: $0.01 (unch); Quick Assets: $2.5M (-37.5%).
- No guidance given.